Document is current
Any future updates will be listed below
-
Authors
Zhang, Xiuli
Goedegebuure, S. Peter
Chen, Michael Y.
Mishra, Rashmi
Zhang, Felicia
Yu, Yik Yeung
Singhal, Kartik
Li, Lijin
Gao, Feng
Myers, Nancy B.
Vickery, Tammi
Hundal, Jasreet
McLellan, Michael D.
Sturmoski, Mark A.
Kim, Samuel W.
Chen, Ina
Davidson, Jesse T. 4th
Sankpal, Narendra V.
Myles, Stephanie
Suresh, Rama
Ma, Cynthia X.
Foluso, Ademuyiwa
Wang-Gillam, Andrea
Davies, Sherri
Hagemann, Ian S.
Mardis, Elaine R.
Griffith, Obi
Griffith, Malachi
Miller, Christopher A.
Hansen, Ted H.
Fleming, Timothy P.
Schreiber, Robert D.
Gillanders, William E. https://orcid.org/0000-0002-0465-3071
-
Funding
Funding for this research was provided by:
National Cancer Institute (P30-CA091842, training grant T32 CA009621, U01 CA248235)
Centene Corporation (P19-00559 B101)
Susan G. Komen for the Cure (KG111025)
Alvin J. Siteman Cancer Center (Investment Program grant 4035)
National Institute of Health (R01 CA240983)
Foundation for Barnes-Jewish Hospital
- License Information
-
More Information
Article History
Received: 26 November 2023
Accepted: 20 September 2024
First Online: 14 November 2024
Declarations
:
: The clinical protocol was reviewed and approved by the Institutional Review Board (ID# 201505074) at Washington University School of Medicine. The research conformed to the principles of the Helsinki/Tokyo/Venice Declaration on experimentation in humans.
: Written consent for publication was obtained from all participating patients.
: K.S., M.G., and O.G. are consultants for the Jaime Leandro Foundation. All other authors declare that they have no competing interests.
